News publication
Everything we hold that mirugen.com published.
Every article we hold from mirugen.com.
Mirugen, a Melbourne biotech spun out of an eye research institute, has closed a A$4.5m seed round with three backers and hired Charlotte Casebourne Stock as chair and acting chief executive.
Also cera.org.au·Brandon BioCatalyst portfolio·insightnews.com.au
Deals recorded from mirugen.com's coverage. A round is listed once, however many of their articles mention it.
Companies named in mirugen.com's articles, most-covered first.
| Company | What it does | Articles |
|---|---|---|
| Brandon BioCatalyst | Investment fund and incubator for biomedical research discoveries | 1 |
| Centre for Eye Research Australia | 1 | |
| CSIRO | Australia's national science research agency, from which Terria spun out | 1 |
| CUREator | 1 | |
| Medical Research Future Fund | 1 | |
| Mirugen | Aims to restore vision in patients with incurable blindness by developing a novel gene th… | 1 |
| Tanarra Capital | 1 | |
| Theolytics | 1 | |
| Yarvie | 1 |
Investors named in mirugen.com's articles, most-covered first.
| Investor | What it does | Articles |
|---|---|---|
| Brandon Capital | 1 | |
| Breakthrough Victoria | 1 | |
| Tin Alley Ventures | Venture fund investing in deep tech startups | 1 |
| University of Melbourne | University operating the Melbourne Connect innovation precinct | 1 |
| University of Melbourne Genesis Pre-Seed Fund | 1 |